Anti-infectives: the way forward
Chopra, I.
Idrugs the Investigational Drugs Journal 5(8): 800-803
2002
ISSN/ISBN: 1369-7056 PMID: 14686383 Document Number: 550925
Document emailed within 1 workday
Related Documents
Gravenstede, S. 2003: Clinical Microbiology and Infectious Diseases--13th European Congress: anti-infectives and resistance, 10-13 May, Glasgow, UK IDrugs: the investigational drugs journal 6(6): 505-508Trissel, L.A.; Parks, N.P.; Santiago, N.M. 1991: Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection American Journal of Hospital Pharmacy 48(10): 2186-2189
Kano, S. 1999: Serological diagnosis of streptococcal infection (anti-streptolysin O; ASO, anti-streptokinase; ASK, anti-deoxyribonuclease B; ADNB, anti-hyaluronidase; AHD, anti-streptococcal polysaccharide; ASP) Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 107-116
Kazimierska, E.; Górski, J. 1989: Anti-HBS, anti-CMV, and anti-HIV antibodies and HBS antigen in patients with hemophilia, malignant lymphomas, leukemias and multiple myeloma Acta Haematologica Polonica 20(2): 189-194
Zivković, V.; Stanković, A.; Cvetković, T.; Mitić, B.; Kostić, S.; Nedović, J.; Stamenković, B. 2014: Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus Srpski Arhiv Za Celokupno Lekarstvo 142(7-8): 431-436
Lebacq, A.M.; Goffinet, P.; De Bruyere, M.; Rodhain, J.; Sokal, G. 1982: Membrane marker studies with anti-T, anti-Ia (DR) and anti-myeloblast antisera in acute leukaemias European Journal of Cancer and Clinical Oncology 18(2): 147-153
Kumagai, T.; Kameko, M.; Kanai, M.; Maruyama, K. 1985: A study on autoantibodies including anti-nDNA, anti-RNP and anti-Sm antibody in various autoimmune diseases Rinsho Byori. Japanese Journal of Clinical Pathology 33(3): 293-297
Locht, H.; Pelck, R.; Manthorpe, R. 2008: Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome Journal of Rheumatology 35(5): 845-849
Devaux, C.; Pierres, M. 1982: Clonal analysis of B and T cell responses to Ia antigens. III. Characterization of 12 xenogeneic anti-idiotypic antisera to A.TH-derived anti-I-Ak and anti-I-Ek monoclonal antibodies Journal of Immunology 128(2): 751-757
Tanaka, M. 2005: RA-related autoantibodies (anti-calpastatin, anti-gp130-RAPS, and anti-FRP antibodies) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 7): 449-452
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Ogutu, E.O.; Amayo, E.O.; Okoth, F.; Lule, G.N. 1990: The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS) East African Medical Journal 67(5): 355-358
Birdsall, H.H.; Rossen, R.D. 1983: Characterization of anti-Fab' antibodies in human sera: identification of soluble immune complexes that contain hidden anti-KLH and blocking anti-immunoglobulins following immunization with keyhole limpet haemocyanin Clinical and Experimental Immunology 53(2): 497-504
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Williams, R.C.; Malone, C.C.; Silvestris, F.; Nickerson, K.G. 1997: Benign monoclonal gammopathy with IgG anti-DNA, anti-Sm and anti-F(ab')2 activity Clinical and Experimental Rheumatology 15(1): 33-38
Nakamura, H.; Kadokawa, T.; Nakatsuji, K.; Nakamura, K. 1970: Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity Arzneimittel-Forschung 20(8): 1032-1046
Wager, O.; Räsänen, J.A.; Haltia, K.; Wasastjerna, C. 1971: M components with antibody activity. Anti-smooth muscle, anti-thyroglobulin and anti-streptolysin-O activity in five M component sera Annals of Clinical Research 3(2): 86-97
Hébert, J.; Bernier, D.; Boutin, Y.; Jobin, M.; Mourad, W. 1990: Generation of anti-idiotypic and anti-anti-idiotypic monoclonal antibodies in the same fusion. Support of Jerne's Network Theory Journal of Immunology 144(11): 4256-4261
Førre, O.; Gaarder, P.I.; Natvig, J.B. 1977: VH subgroup restriction in human erythrocyte antibodies: Studies of anti-A, anti-B, and anti-Duffy antibodies Scandinavian Journal of Immunology 6(1-2): 149-156